These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 7727810)

  • 1. A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter.
    Reeves JH; Butt WW
    ASAIO J; 1995; 41(1):100-4. PubMed ID: 7727810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cellulose triacetate dialyzer and polysulfone synthetic hemofilter for continuous venovenous hemofiltration in acute renal failure.
    Pichaiwong W; Leelahavanichkul A; Eiam-ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S65-72. PubMed ID: 17044456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous venovenous hemodialysis in a neonate model: a two-pump system.
    Jouvet P; Colomer S; Jugie M; Meftali Y; Vassault A; Man NK
    Crit Care Med; 1998 Jan; 26(1):115-9. PubMed ID: 9428552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extrarenal elimination procedures in acute kidney failure].
    Sold M
    Anaesthesist; 1990 Nov; 39(11):569-86. PubMed ID: 2288406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solute clearance in continuous venovenous hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone membranes.
    Ifediora OC; Teehan BP; Sigler MH
    ASAIO J; 1992; 38(3):M697-701. PubMed ID: 1457952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialyzer fiber bundle volume and kinetics of solute removal in continuous venovenous hemodialysis.
    Liangos O; Sakiewicz PG; Kanagasundaram NS; Hammel J; Pajouh M; Seifert T; Paganini EP
    Am J Kidney Dis; 2002 May; 39(5):1047-53. PubMed ID: 11979349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clearance of protein-bound solutes by hemofiltration and hemodiafiltration.
    Meyer TW; Walther JL; Pagtalunan ME; Martinez AW; Torkamani A; Fong PD; Recht NS; Robertson CR; Hostetter TH
    Kidney Int; 2005 Aug; 68(2):867-77. PubMed ID: 16014068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic continuous venovenous hemodiafiltration in cardiosurgical patients.
    Caprioli R; Favilla G; Palmarini D; Comite C; Gemignani R; Rindi P; Cioni L
    ASAIO J; 1993; 39(3):M606-8. PubMed ID: 8268609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast medium-removing effect of hemofiltration and hemodiafiltration.
    Okahisa T; Sogabe M; Hayashi S; Shibata H; Ito S
    J Med Invest; 1998 Aug; 45(1-4):87-93. PubMed ID: 9864968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.
    Isla A; Maynar J; Sánchez-Izquierdo JA; Gascón AR; Arzuaga A; Corral E; Pedraz JL
    J Clin Pharmacol; 2005 Nov; 45(11):1294-304. PubMed ID: 16239363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
    Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
    Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Sánchez-Izquierdo JA; Pedraz JL
    Chemotherapy; 2007; 53(3):194-201. PubMed ID: 17356270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting urea clearance during continuous hemodiafiltration in the canine model.
    Hiyama DT; Weiss RG; Ryckman FC
    J Pediatr Surg; 1989 Aug; 24(8):756-9. PubMed ID: 2769542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system.
    Jeffrey RF; Khan AA; Prabhu P; Todd N; Goutcher E; Will EJ; Davison AM
    Artif Organs; 1994 Jun; 18(6):425-8. PubMed ID: 8060251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.